ACTIVITY-DEPENDENT NEUROTROPHIC FACTOR (ADNF) III
European Patent
98907407.5
Filed on 1998-02-06
98907407.5
Filed on 1998-02-06
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Switzerland
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Sweden
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Spain
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
The Netherlands
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Greece
3034562
Filed on 1997-04-30
3034562
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Denmark
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Belgium
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Austria
97923523.1
Filed on 1997-04-30
97923523.1
Filed on 1997-04-30
ACTIVITY-DEPENDENT NEUROTROPHIC FACTOR III (ADNF III)
European Patent
99971817.4
Filed on 1999-11-04
99971817.4
Filed on 1999-11-04